$ASX

ASE Technology Holding Co., Ltd. Reports Its Unaudited Consolidated Financial Results for the Second Quarter of 2026

ASE Technology Holding Co. (TWSE:3711, NYSE:ASX) reported unaudited 2Q26 results. Net revenues were NT$191,064 million, up 26.7% YoY and 10.0% QoQ. Net income attributable to shareholders was NT$21,068 million. Basic EPS was NT$4.80. Gross margin rose to 21.0% and operating margin to 11.1%.

Original reporting
Published Jul 30, 2026, 8:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 8:09 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$ASX
Bullish
high confidence
Mentioned
$ASX
Relevance
8/10
alphai data visualization · based on prnewswire.com
Decision brief

The 30-second read

$ASXBullishMed
01

Why it matters

Consolidated results show strong YoY and sequential revenue growth, higher net income and EPS, and sequential gross margin improvement. Segment detail indicates ATM margins improved while EMS margins softened, shaping how traders may model mix and 2H26 profitability.

02

Market read

Traders can update near-term earnings expectations based on the reported revenue acceleration, EPS jump, and sequential margin improvement, while monitoring EMS margin softness and customer concentration risk.

03

What to watch

Customer concentration remains high (top customers represent large shares of revenue), and raw material costs are a major cost driver (45% of net revenues), which could pressure margins if input costs rise.

Relevance 8/10Novelty 8/10Timing: pre-market today (earnings release published 2026-07-30 08:00 UTC)

Background

ASE Technology Holding Co. (ASEH) is a leading semiconductor assembly and testing (ATM) and electronic manufacturing services (EMS) provider; this is its unaudited 2Q26 financial results release.

Company-level read

Ticker impact

$ASXBullishHigh confidence
Context

ASE Technology reported 2Q26 net revenues of NT$191,064 million, up 26.7% YoY and 10.0% sequentially, with EPS rising sharply.

Expected impact

Likely positive for the stock, with upside skew if investors extrapolate the margin and revenue momentum into 2H26.

Evidence & confidence

The release provides multiple directionally supportive datapoints: revenue growth, higher net income attributable to shareholders, and gross margin up to 21.0% from 20.0% sequentially.

Market effects

ATM/EMS peers may see read-across demand and margin expectations given ASE’s packaging/testing strength versus EMS margin softness.

Taiwan semiconductor services results can influence sentiment for regional assembly and test supply chains.

Global outsourced semiconductor manufacturing demand signals may affect broader risk appetite in the semiconductor services complex.

Counterpoint

EMS segment profitability declined sequentially (gross margin down, operating margin down), which could limit multiple expansion despite consolidated strength.

Key entities

  • ASE Technology Holding Co., Ltd.

    Subject of the press release, reporting unaudited 2Q26 consolidated and segment financial results.

  • Semiconductor assembly and testing (ATM)

    One of ASE’s main segments; reported higher revenues and improved gross and operating margins in 2Q26.

  • Electronic manufacturing services (EMS)

    Another main segment; reported revenue growth but margin compression in 2Q26.

Related articles

$ASXMedAI 8/10

ASE (ASX) Q2 2026 Earnings Call Transcript

ASE Technology Holding Co. reported Q2 2026 revenue of TWD 191.1B (+10% sequential, +27% YoY) and net income of TWD 21.1B (+49% sequential, +180% YoY). ATM revenue was TWD 126.1B, gross margin 27.3%. Management raised annual CapEx guidance to $10.5B and guided Q3 revenue +21% to +22% sequential.

$ASXMedAI 8/10

Taiwan's ASE Tech raises 2026 capex by $2 billion on strong demand

ASE Technology Holding said it will raise 2024 capex by $2 billion to about $10.5 billion due to strong demand. The increase is split between $1 billion for facilities and $1 billion for equipment. It expects LEAP revenue to track ahead of 2026 guidance of $3.5 billion and aims to double LEAP revenue in 2027. Q2 revenue rose to T$191.06 billion and net income to T$21.068 billion.

$ASXMed

ASE Technology Q2 Earnings Call Highlights

ASE Technology (NYSE:ASX) reported Q2 EMS revenue of TWD 65.8B, up 6% sequentially and 12% YoY, but gross margin fell to 8.9% and operating margin to 2.4% due to product mix and higher component costs. Q3 guidance calls for 21% to 22% NTD revenue growth and 11.5% to 12.5% operating margin. Capex rises toward 2026.

$ASXMed

Larvotto digs in as Hammer takeover battle heats up

Larvotto Resources defended its June scheme to acquire Hammer Metals after Austral Resources made a competing indicative all-scrip proposal. Larvotto said Austral’s offer is non-binding and would require due diligence and deal documents. Hammer shareholders would get 1 Larvotto share for 22 Hammer shares, valuing it at 5.6c. Glencore backed Larvotto with $15m and a 7-year gold concentrate offtake.

$ASXMedAI 8/10

ASX Admits Misleading Conduct On CHESS Project, To Pay A$20.5 Mln Penalty In Settlement With ASIC

ASX Limited said it has settled ASIC proceedings over misleading statements made in 2022 about the CHESS replacement project. ASX admitted contravening ASIC Act provisions, including a “progressing well” representation. The settlement requires a A$20.5 million penalty plus A$3 million toward ASIC legal costs, subject to Federal Court approval, ending the trial.

$ASXMed

ASX to pay $20.5m penalty for misleading market

ASX Ltd will pay a $20.5m penalty and $3m in ASIC legal costs to settle claims it made a misleading statement about its CHESS clearing and settlement upgrade, according to ASIC. ASIC says ASX told investors in Feb 2022 the project was “progressing well,” then later flagged a likely delay. ASX scrapped the project and wrote off $245m–$255m; the settlement avoids trial pending Federal Court approval.